EFPIA - NEWSLETTER

EFPIA Newsletter 06 March 2025

News

05 March 2025 A Call for Effective Stakeholder Engagement and Capacity Building during the Implementation...

39 representatives of the EU health community welcome the publication of the EHDS in the Official Journal of the EU....

03 March 2025 EFPIA seeks clarity on Urban Wastewater Treatment Directive in the European Courts

Europe needs environmental legislation that works, where all sectors are incentivised to sustainably reduce micro-pollutants...

Blogs

05 March 2025 Cancer care 2030: from policy ambition to impact (Guest blog)

Why is it important to continue the Europe's Beating Cancer Plan?

04 March 2025 World Obesity Day: a chronic disease demands urgent action

Scientific understanding and clinical management of obesity have evolved, but attitudes, policies and societal narratives...

IMAGINE a healthier, more competitive Europe: Interview with Monica Shaw

In this short video, Monica Shaw, SVP, Commercial Head Cell Therapy at BMS, shares her perspective on the urgent need for policies that support investment in R&D, strengthen Europe’s competitiveness, and ensure faster, more equitable access to medicines for patients.

Watch here to hear her insights on the path to a healthier future for Europe.

Events

19 MAR 2025

Cancer Care 2030: From policy ambition to impact Brussels, Belgium

Join us on 19 March in Brussels to discuss how we can work together to accelerate progress to improve cancer care

Learn more →

03 APR 2025

Unlocking efficiency through reliance: Navigating the EMA post-authorization framework... Virtual event

Learn more →

2024 Pipeline: Obesity

Imagine if weight-loss treatments could lower the risk of diabetes, cardiovascular disease and stroke, helping people to live healthier lives.

Discover more in our pipeline review.

What we are reading

Europe is losing clinical trials to China, while a key legislative proposal has now been postponed... 05 March 2025 (Dagens Pharma)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶